Semaglutide and Tirzepatide are two of the most talked-about weight loss peptides of the decade. Both are GLP-1 receptor agonists that dramatically suppress appetite and promote fat loss — but they work slightly differently and produce different levels of results.

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist that mimics the glucagon-like peptide-1 hormone. It reduces appetite, slows gastric emptying and improves insulin sensitivity. It is the active ingredient in Ozempic and Wegovy. Clinical trials show an average weight loss of 15% of body weight over 68 weeks.

What is Tirzepatide?

Tirzepatide is a dual GLP-1 and GIP receptor agonist — meaning it activates TWO hormone pathways instead of one. This dual action makes it more powerful than semaglutide. It is the active ingredient in Mounjaro and Zepbound. Clinical trials show an average weight loss of 20–22% of body weight — significantly more than semaglutide.

Head to Head Comparison

Which Should You Choose?

Choose Semaglutide if you are new to GLP-1 peptides and want to start with a well-researched, proven option with a long safety track record.

Choose Tirzepatide if you want maximum fat loss results. The dual mechanism makes it significantly more powerful and studies consistently show greater weight loss than semaglutide alone.

Dosage Protocol